Robert Kolb has been named chief information officer of Alere Medical (Reno, Nevada), a provider of care management and remote monitoring of patients with advanced heart failure. He earlier founded First Step, a health care software engineering and technology consulting firm, and has been with Alere for four years, during which he created a system that supports congestive heart failure patients from their homes.
David Hall has been named chief financial officer for Angiotech Pharmaceuticals (Vancouver, British Columbia, Canada). Hall is one of the company's business founders and most recently was senior vice president, finance, secretary and treasurer. Angiotech is focused on developing medical device coatings and treatments for chronic inflammatory diseases through reformulation of paclitaxel.
Daniel Mulvena has been named chairman of the board of Cambridge Heart (Bedford, Massachusetts), replacing Jeffrey Arnold, who resigned the post last week. Mulvena has served as a member of the company's board of directors since 1999. He is a founding partner of Commodore Associates, a consulting firm for medical device and service companies, and previously held held senior management positions at Boston Scientific and C.R. Bard. Arnold joined Cambridge Heart in 1993 as president and CEO and was elected chairman in 1997. He served as president of the company until October 2000 and as CEO until February. Cambridge Heart is the developer of the Microvolt T-Wave Alternans Test.
Gerald Seery has been named president and CEO of CryoLife Europa, the European subsidiary of CryoLife (Atlanta, Georgia). Previously, Seery served as president of AuraZyme Pharmaceuticals, a subsidiary of CryoLife. CryoLife develops implantable living human tissues for use in cardiovascular, vascular and orthopedic surgeries.
Paul Mooney, president of the Surgical Products Group of Maxxim Medical (Boston, Massachusetts), has assumed added responsibility for Maxxim's Vascular Group business, which makes vascular devices and cath lab custom procedure trays. Mooney has been with Maxxim Medical since September 2001.
Taffy Williams, PhD, president, CEO and a director of Photogen Technologies (New Hope, Pennsylvania), is temporarily taking over additional duties as chairman of the company, with the anticipated resignation of Theodore Tannebaum,due to health difficulties. Photogen Technologies is developing a platform of products in cardiovascular imaging and diagnosis of cancer metastasizing to lymph nodes.